The objective of the FIT in a randomized, prospective to see if to see if could with a single dose of Zevalin as first-line consolidation therapy achieve this important goal. The full results from the Phase 3 FIT study will be presented at the 49th Annual Meeting of the American Society of Hematology in the Georgia World Congress Center in Atlanta, Georgia, from 8-11 December 2007:.. In the study, patients received either Zevalin or no further treatment after receiving at least a partial response to initial induction therapy.

[90Y] – ibritumomab tiuxetan consolidation of first remission in advanced stage follicular NHL first results of the first results of the international, randomized Phase 3 first-line Indolent Trial Abstract# 643rd Oral Presentation: Monday, 10 December 15, Room A411-A412.Seventy % of the Inuit people preschool children in Nunavut, Canada lives largest region found in homes, Dining where does not is not sufficiently, the situation with a affect children’s academic and psychosocial development, an item in the CMAJ .